Contrast-enhanced Mammography: State of the Art.
TLDR
Contrastenhanced mammography (CEM) has emerged as a viable alternative to contrast-enhanced breast MRI, and it may increase access to vascular imaging while reducing examination cost as discussed by the authors.Abstract:
Contrast-enhanced mammography (CEM) has emerged as a viable alternative to contrast-enhanced breast MRI, and it may increase access to vascular imaging while reducing examination cost. Intravenous iodinated contrast materials are used in CEM to enhance the visualization of tumor neovascularity. After injection, imaging is performed with dual-energy digital mammography, which helps provide a low-energy image and a recombined or iodine image that depict enhancing lesions in the breast. CEM has been demonstrated to help improve accuracy compared with digital mammography and US in women with abnormal screening mammographic findings or symptoms of breast cancer. It has also been demonstrated to approach the accuracy of breast MRI in preoperative staging of patients with breast cancer and in monitoring response after neoadjuvant chemotherapy. There are early encouraging results from trials evaluating CEM in the screening of women who are at an increased risk of breast cancer. Although CEM is a promising tool, it slightly increases radiation dose and carries a small risk of adverse reactions to contrast materials. This review details the CEM technique, diagnostic and screening uses, and future applications, including artificial intelligence and radiomics.read more
Citations
More filters
Journal ArticleDOI
Contrast-enhanced Mammography: A Systematic Review and Meta-Analysis of Diagnostic Performance
TL;DR: A systematic review and meta-analysis of CEM diagnostic performance considering different interpretation methods and clinical settings was performed by Bahl et al. as mentioned in this paper , who found that CEM demonstrated high performance in breast cancer detection, especially with joint interpretation of low-energy and recombined images.
Journal ArticleDOI
Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis.
TL;DR: Comparison of CEM and CE-MRI regarding sensitivity, specificity, and negative predictive value in detecting breast cancer, involving all publicly available studies in the English language found Contrast-enhanced MRI had superior sensitivity and negative likelihood ratios with higher pretest probabilities to rule out malignancy compared with contrast-enhancing mammography.
Journal ArticleDOI
Contrast enhanced mammography (CEM) versus magnetic resonance imaging (MRI) for staging of breast cancer: The pro CEM perspective.
TL;DR: In this article, the authors consider the combination of contrast enhanced mammography (CEM) and US as a single appointment imaging strategy for preoperative staging of breast cancer, and conclude that there is only limited room for an additional benefit of breast MRI.
Journal ArticleDOI
Contrast-enhanced mammography: what the radiologist needs to know
Lidewij M.F.H. Neeter,H.P.J. (Frank) Raat,Rodrigo Alcantara,Quirien Robbe,Marjolein L. Smidt,Joachim E. Wildberger,Marc B. I. Lobbes +6 more
TL;DR: This comprehensive review provides a practical overview of C EM technique, including CEM-guided biopsy; reading, interpretation and structured reporting of CEM images, including the accompanying learning curve, CEM artefacts and interpretation pitfalls; indications for CEM; disadvantages of Cem; and future developments.
Journal ArticleDOI
Mammography-based Radiomics in Breast Cancer: A Scoping Review of Current Knowledge and Future Needs.
TL;DR: The potential role of mammography-based radiomics appears promising but more efforts are required to further evaluate its reliability as a routine clinical tool as discussed by the authors, and the role of integrating radiomics with other information is discussed.
References
More filters
Journal ArticleDOI
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Debbie Saslow,Carla Boetes,Wylie Burke,Steven E. Harms,Martin O. Leach,Constance D. Lehman,Elizabeth A. Morris,Etta D. Pisano,Mitchell D. Schnall,Stephen F. Sener,Robert A. Smith,Ellen Warner,Martin J. Yaffe,Kimberly S. Andrews,Christy A. Russell +14 more
TL;DR: There are several risk subgroups for which the available data are insufficient to recommend for or against screening, including women with a personal history of breast cancer, carcinoma in situ, atypical hyperplasia, and extremely dense breasts on mammography.
Journal ArticleDOI
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.
Patricia A. Carney,Diana L. Miglioretti,Bonnie C. Yankaskas,Karla Kerlikowske,Robert D. Rosenberg,Carolyn M. Rutter,Berta M. Geller,Linn Abraham,Steven H. Taplin,Mark Dignan,Gary Cutter,Rachel Ballard-Barbash +11 more
TL;DR: The accuracy of screening mammography is best in older women and in women with fatty breasts, and the individual and combined effects of age, breast density, and HRT use on mammographic accuracy are examined.
Journal ArticleDOI
The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice.
TL;DR: The pathophysiologic basis of breast MR and the effects on acquisition technique and diagnostic accuracy, the diverging demands of high spatial and temporal resolution, and the different approaches that exist for image acquisition are reviewed.
Journal ArticleDOI
Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma.
Maxine S. Jochelson,D. David Dershaw,Janice S. Sung,Alexandra S. Heerdt,Cynthia M Thornton,Chaya S. Moskowitz,Jessica Ferrara,Elizabeth A. Morris +7 more
TL;DR: Bilateral dual-energy contrast agent-enhanced digital mammography was feasible and easily accomplished and was used to detect known primary tumors at a rate comparable to that of MR imaging and higher than that of conventionaldigital mammography.
Journal ArticleDOI
Prevalence of Mammographically Dense Breasts in the United States
Brian L. Sprague,Ronald E. Gangnon,Veronica Burt,Amy Trentham-Dietz,John M. Hampton,Robert D. Wellman,Karla Kerlikowske,Diana L. Miglioretti +7 more
TL;DR: The prevalence of dense breasts among US women of common breast cancer screening ages exceeds 25 million and policymakers and healthcare providers should consider this large prevalence when debating breast density notification legislation and designing strategies to ensure that women who are notified have opportunities to evaluate breast cancer risk.